Wide Ranks

A

Agilent Technologies, Inc.

138.14

Top Statistics
Market Cap 39 B Forward PE 24.94 Revenue Growth -5.60 %
Current Ratio 1.78 Trailing PE 31.18 Earnings Growth 156.90 %
Profit Margins 21.75 % Peg Ratio Dividend Yield 0.74 %
Enterprice / EBITA 25.56 Enterprise / Revenue 6.15 Price To Sales Trailing12 Months 6.06
Profitability
Profit Margins 21.75 % Operating Margins 24.97 %
Balance Sheet
Total Cash 1 B Total Cash Per Share 6.19 Total Debt 3 B
Total Debt To Equity 52.79 Current Ratio 1.78 Book Value Per Share 20.53
All Measures
Short Ratio 259.00 % Fax 866 497 1134 Shares Short Prior Month 3 M
Return On Equity 0.2466 City Santa Clara Uuid 7fc56270-e7a7-3fa8-9a59-35b72eacbe29
Previous Close 134.37 First Trade Date Epoch Utc 942 M Book Value 20.53
Beta 1.07 Total Debt 3 B Volume 2 M
Price To Book 6.73 Last Split Date 1 B Fifty Two Week Low 124.16
Total Cash Per Share 6.19 Total Revenue 6 B Shares Short Previous Month Date 1 B
Target Median Price 150.00 Audit Risk 9 Max Age 86400
Recommendation Mean 2.30 Operating Margins 24.97 % Target Mean Price 148.64
Net Income To Common 1 B Ask 138.47 Short Percent Of Float 0.0136
Trailing Peg Ratio 234.14 % Last Fiscal Year End 1 B Average Daily Volume10 Day 2 M
Average Volume10days 2 M Total Cash 1 B Next Fiscal Year End 1 B
Revenue Per Share 22.27 Held Percent Insiders 0.0028 Ebitda Margins 24.07 %
Dividend Rate 0.9900 Trailing PE 31.18 Date Short Interest 1 B
Most Recent Quarter 1 B Share Holder Rights Risk 9 Regular Market Previous Close 134.37
Target Low Price 135.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 137.72
Open 134.69 Dividend Yield 0.74 % State CA
Free Cashflow 879 M Return On Assets 0.0758 Time Zone Short Name EST
Board Risk 4 Trailing Eps 4.43 Day Low 134.24
Address1 5301 Stevens Creek Boulevard Shares Outstanding 285 M Compensation Risk 4
Price Hint 2 Target High Price 165.00 Website https://www.agilent.com
Average Volume 1 M Earnings Quarterly Growth 154.10 % Forward Eps 5.65
Recommendation Key buy Compensation As Of Epoch Date 1 B Quick Ratio 125.80 %
Last Split Factor 1398:1000 Is_sp_500 True Regular Market Day High 139.00
Profit Margins 21.75 % Debt To Equity 52.79 Fifty Two Week High 155.35
Day High 139.00 Shares Short 3 M Regular Market Open 134.69
Bid 133.64 Earnings Growth 156.90 % Enterprise To Revenue 6.15
Revenue Growth -5.60 % Shares Percent Shares Out 0.0120 Operating Cashflow 1 B
Five Year Avg Dividend Yield 66.00 % Currency USD Market Cap 39 B
Time Zone Full Name America/New_York Is_nasdaq_100 False Zip 95051
Payout Ratio 19.40 % Quote Type EQUITY Industry Diagnostics & Research
Ex Dividend Date 1 B Overall Risk 8 Regular Market Day Low 134.24
Held Percent Institutions 0.9126 Long Name Agilent Technologies, Inc. Enterprise To Ebitda 25.56
Current Price 138.14 Financial Currency USD Current Ratio 1.78
Gross Margins 54.39 % Number Of Analyst Opinions 17 Country United States
Float Shares 286 M Two Hundred Day Average 138.55 Governance Epoch Date 1 B
Enterprise Value 39 B Price To Sales Trailing12 Months 6.06 Forward PE 24.94
Regular Market Volume 2 M Ebitda 1 B Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha 
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab.

The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses.

The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services.

The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce.

Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.